New heart valve device aims to save lives without Open-Heart surgery
NCT ID NCT07278310
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new device called the Siegel TAVR System to replace a narrowed heart valve in people with severe aortic stenosis. About 1,025 participants with symptoms will receive the device. Researchers will track deaths, strokes, and heart-related hospitalizations for one year to see if the device is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Siegel TAVR Device (a replacement heart valve implanted via catheter)
What this could lead to
If successful, this could offer a safer, more effective option for replacing a narrowed heart valve without open-heart surgery.
What could go wrong
This is a large trial, but the device is new and may have unknown risks. Results will take time, and not all patients may benefit equally.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Piedmont Heart Institute
RECRUITINGAtlanta, Georgia, 30309, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact